IP Library Patent Application 13885168
Patent Application
App. No. 13/885,168

Multivalent Vaccine for Filariasis

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/885,168
Abstract

The present invention is a multivalent vaccine for immunizing an animal against filariasis. In some embodiments, the antigens of the multivalent vaccine are protein-based, DNA-based, or a combination thereof.

Claims (15)

1 . A multivalent vaccine comprising two or more isolated antigens from one or more filarial nematodes.

2 . The multivalent vaccine of claim 1 , wherein the filarial nematodes are selected from the group of Brugia malayi, Wuchereria Bancroft, Onchocerca volvulus, Loa loa and Brugia timori.

3 . The multivalent vaccine of claim 1 , wherein the antigens are protein-based, DNA-based, or a combination thereof.

4 . The multivalent vaccine of claim 1 , wherein the antigens comprise Abundant Larval Transcript (ALT-2), Tetraspanin or Small heat shock protein (HSP) 12.6, or fragments thereof.

5 . The multivalent vaccine of claim 4 , wherein the fragment is selected from the group of SEQ ID NO:39, SEQ ID NO:40, SEQ ID NO:63, SEQ ID NO:64, SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, and SEQ ID NO:69.

6 . The multivalent vaccine of claim 1 , wherein the antigens are covalently attached.

7 . A recombinant vector comprising two or more isolated DNA-based antigens from one or more filarial nematodes.

8 . The recombinant vector of claim 7 , wherein the antigens comprise Abundant Larval Transcript (ALT-2), Tetraspanin or Small heat shock protein (HSP) 12.6.

9 . The recombinant vector of claim 8 , wherein the antigen is selected from the group of SEQ ID NO:40, SEQ ID NO:65, SEQ ID NO:66, SEQ ID NO:67, SEQ ID NO:68, and SEQ ID NO:69.

10 . An expression vector comprising two or more isolated nucleic acid molecules from one or more filarial nematodes, wherein said nucleic acid molecules encode protein-based antigens.

11 . The expression vector of claim 10 , wherein the antigens comprise Abundant Larval Transcript (ALT-2), Tetraspanin or Small heat shock protein (HSP) 12.6.

12 . The expression vector of claim 11 , wherein the antigen is selected from the group of SEQ ID NO:39, SEQ ID NO:63 and SEQ ID NO:64.

13 . A recombinant host cell comprising the recombinant vector of claim 7 .

14 . A recombinant host cell comprising the expression vector of claim 10 .

15 . A method for immunizing an animal against filariasis comprising administering to an animal in need thereof the multivalent vaccine of claim 1 thereby immunizing the animal against filariasis.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 14, 2019
From: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
To: NIH
Reel/Frame 048597/0778 →
CONFIRMATORY LICENSE Recorded Aug 20, 2013
From: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS ON BEHALF OF ITS OFFICE OF TECHNOLOGY MANAGEMENT OFFICE AT THE UNIVERSITY OF ILLINOIS AT CHICAGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031043/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2013
From: KALYANASUNDARAM, RAMASWAMY
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 030409/0422 →